Effective Suppression of Hypoxia Induced Angiogenesis by Synergism of Simvastatin and Metformin via Inhibiting ET-1-ETBR-Hif1α Signaling Axis
Jie Liu(BGI Group (China)), Peijun Liu(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 0
Related Papers
Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation
|Journal of Experimental & Clinical Cancer Research|2019|141
Suppression of tumor angiogenesis by metformin treatment<i>via</i>a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
|Oncotarget|2015|107
Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cells
|Scientific Reports|2017|66